J.Safra Asset Management Corp has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity portfolio as of the close of business on September 30, 2026. The filing, signed by Chief Compliance Officer Fernanda Bomfim, lists a total of 1,019 positions held by the firm.
The top holdings in the portfolio include major technology and healthcare names. Alphabet Inc. (Class A and Class C) is the largest position, with 29,678 shares of Class A and 64,848 shares of Class C. Other significant technology holdings include Tesla Inc. with 12,960 shares, Amazon.com Inc. with 41,457 shares, and Visa Inc. with 13,029 shares. In the healthcare sector, UnitedHealth Group Inc. is listed with 5,620 shares, while AbbVie Inc. holds 5,901 shares.
Other notable positions include Broadcom Inc. with 16,380 shares, Eli Lilly and Company with 14,234 shares, Merck & Co. Inc. with 4,743 shares, and Eli Lilly and Company with 14,234 shares. The filing also lists positions in consumer staples and industrial companies, such as Procter & Gamble Co. with 537 shares, Johnson & Johnson with 8678 shares, and Chevron Inc. with 1,313 shares.
The filing details that all positions are held for investment purposes, with sole voting rights and no shared investment power for the shares listed.
